Leading American cancer centers endorse HPV vaccination for cancer prevention
1/28/2016
Roswell Park Cancer Institute (RPCI) has joined with all the top cancer centers across the nation in issuing a statement urging for increased HPV vaccination for the prevention of cancer.
Patient involvement: what is it, and why does it matter?
1/28/2016
Patient engagement involves patients being more active in decisions about their treatment and health care. Why does it matter, how does it work and what can prevent it?
Leading American cancer centers endorse HPV vaccination for cancer prevention
1/28/2016
Roswell Park Cancer Institute (RPCI) has joined with all the top cancer centers across the nation in issuing a statement urging for increased HPV vaccination for the prevention of cancer.
Scientists from the University of Granada have developed a new fluorescent dye capable of detecting, in a single test lasting 20 minutes, the presence of phosphate and biothiol inside living cells.
Novartis has announced that Tafinlar® (dabrafenib) + Mekinist® (trametinib), the first oral targeted combination therapy to be licensed for advanced melanoma, is now available in the UK...
Novartis has announced that Tafinlar® (dabrafenib) + Mekinist® (trametinib), the first oral targeted combination therapy to be licensed for advanced melanoma, is now available in the UK...
New treatment against cancer, combining radiotherapy and stem cell based therapy, developed
1/28/2016
An international team of researchers lead by the University of Granada (UGR) has proven that mesenchymal stem cells (MSC) may be used as enhancer agents of local and systemic effects of...
Researchers mine the epigenome to identify likely origins of childhood brain tumor subtype
1/28/2016
Researchers have identified the cells that likely give rise to the brain tumor subtype Group 4 medulloblastoma.
Basic research led to first FDA-approved immunotherapy for pediatric cancer
1/28/2016
Building upon more than two decades of basic research conducted at Children's Hospital Los Angeles, Araz Marachelian, MD, of CHLA, and her colleagues at pediatric academic centers across the U. S.
Toward a better understanding of the mechanisms blocking cancer cell growth
1/28/2016
DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage.
